Risperidone-induced acromegaly: a case report
| Autor: | Cicek Hocaoglu, Ayse Koroglu |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Paranoid schizophrenia Movement disorders Risperidone business.industry medicine.medical_treatment Disease medicine.disease Acromegaly medicine Endocrine system Psychology (miscellaneous) medicine.symptom Adverse effect Psychiatry Antipsychotic business Letter to the Editor Pharmacology Toxicology and Pharmaceutics (miscellaneous) medicine.drug |
| Zdroj: | Therapeutic Advances in Psychopharmacology. 2:85-89 |
| ISSN: | 2045-1261 2045-1253 |
| DOI: | 10.1177/2045125311433581 |
| Popis: | Today, considering their adverse side effects, the first-generation antipsychotics have been replaced by the new-generation antipsychotics (also known as second-generation antipsychotic agents). The superiority of new-generation antipsychotics compared with first-generation antipsychotic agents in terms of side effects, especially movement disorders, are acknowledged by clinicians. But in recent years during the use of second-generation antipsychotic agents, endocrine side effects have been noteworthy. In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|